IRADIMED CORPORATION (IRMD) Gross Margin
- Gross margin · 12 months: Value 75.86%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 75.86% | Gross profit / revenue. Period ending 2026-06-30. $65.50M ÷ $86.34M × 100 ≈ 75.86% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 65.50M USD | Gross Profit |
| Revenue | 86.34M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $65.50M | $86.34M | (m) | 75.86% |
| 2026-03-31 | $66.30M | $86.28M | (m) | 76.84% |
| 2025-12-31 | $64.32M | $83.81M | (m) | 76.75% |
| 2025-09-30 | $62.05M | $80.51M | (m) | 77.07% |
| 2025-06-30 | $59.75M | $77.64M | (m) | 76.96% |
| 2025-03-31 | $57.80M | $75.15M | (m) | 76.91% |
| 2024-12-31 | $56.35M | $73.24M | (m) | 76.94% |
| 2024-09-30 | $55.00M | $71.31M | (m) | 77.14% |
| 2024-06-30 | $53.65M | $69.48M | (m) | 77.21% |
| 2024-03-31 | $51.82M | $67.69M | (m) | 76.57% |
| 2023-12-31 | $50.16M | $65.56M | (m) | 76.50% |
| 2023-09-30 | $47.97M | $62.97M | (m) | 76.17% |
| 2023-06-30 | $45.67M | $59.88M | (m) | 76.28% |
| 2023-03-31 | $43.62M | $56.47M | (m) | 77.26% |
| 2022-12-31 | $41.28M | $53.30M | (m) | 77.45% |
| 2022-09-30 | $39.31M | $50.31M | (m) | 78.14% |
| 2022-06-30 | $37.17M | $47.81M | (m) | 77.75% |
| 2022-03-31 | $34.37M | $44.90M | (m) | 76.54% |
| 2021-12-31 | $32.05M | $41.81M | (m) | 76.65% |
| 2021-09-30 | $29.24M | $38.49M | (m) | 75.97% |
| 2021-06-30 | $26.58M | $35.28M | (m) | 75.33% |
| 2021-03-31 | $24.17M | $32.26M | (m) | 74.92% |
| 2020-12-31 | $23.57M | $31.72M | (m) | 74.33% |
| 2020-09-30 | $25.28M | $34.06M | (m) | 74.23% |
| 2020-06-30 | $27.34M | $36.33M | (m) | 75.26% |
| 2020-03-31 | $29.78M | $38.76M | (m) | 76.82% |
| 2019-12-31 | $29.70M | $38.52M | (m) | 77.11% |
| 2019-09-30 | $27.91M | $12.64M | (m) | 220.89% |
| 2019-06-30 | $25.90M | $10.29M | (m) | 251.81% |
| 2019-03-31 | $24.20M | $8.44M | (m) | 286.82% |
| 2018-12-31 | $23.23M | $30.44M | (m) | 76.31% |
| 2018-09-30 | $21.94M | $28.80M | (m) | 76.15% |
| 2018-06-30 | $20.53M | $26.88M | (m) | 76.37% |
| 2018-03-31 | $19.15M | $25.03M | (m) | 76.53% |
| 2017-12-31 | $17.51M | $23.08M | (m) | 75.87% |
| 2017-09-30 | $17.13M | $22.37M | (m) | 76.60% |
| 2017-06-30 | $19.02M | $24.35M | (m) | 78.10% |
| 2017-03-31 | $22.86M | $28.69M | (m) | 79.66% |
| 2016-12-31 | $26.34M | $32.50M | (m) | 81.06% |
| 2016-09-30 | $28.95M | $35.31M | (m) | 82.01% |
| 2016-06-30 | $29.29M | $35.83M | (m) | 81.76% |
| 2016-03-31 | $27.35M | $33.57M | (m) | 81.48% |
| 2015-12-31 | $25.75M | $31.59M | (m) | 81.51% |
| 2015-09-30 | $21.12M | $26.38M | (m) | 80.06% |
| 2015-06-30 | $17.37M | $22.00M | (m) | 78.96% |
| 2015-03-31 | $15.01M | $19.09M | (m) | 78.64% |
| 2014-12-31 | $12.25M | $15.65M | (m) | 78.25% |
| 2014-09-30 | (m) | (m) | (m) | (m) |
| 2014-06-30 | (m) | (m) | (m) | (m) |
| 2014-03-31 | (m) | (m) | (m) | (m) |
| 2013-12-31 | $8.49M | $11.34M | (m) | 74.84% |
| 2013-09-30 | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |